ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,324Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 910

$4.36M Total Retail Price of All Prescriptions

Rank: 1 out of 910

253 Patients Receiving at Least One Drug in Part D
10%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

36% of this provider’s 253 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 253 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 1,006 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$353 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
NORVIR 802 82 10 1 138
TRUVADA 637 35 2 145
ACYCLOVIR 450 48 10 3 165
PREZISTA 446 65 4 171
EPZICOM 433 42 10 5 177
ATRIPLA 375 36 10 6 196
LISINOPRIL 353 41 7 2
PRAVASTATIN SODIUM 322 19 8 16
OXYCODONE HCL 314 18 S2 9 42
REYATAZ 268 0 10 217
MORPHINE SULFATE ER 260 15 S2 11 52
GABAPENTIN 249 31 12 13
FLUCONAZOLE 243 16 13 197
HYDROCHLOROTHIAZIDE 240 21 14 12
OMEPRAZOLE 227 12 15 5
VIRAMUNE XR 211 17 10 16 243
OXYCODONE-ACETAMINOPHEN 209 19 S2 17 31
KALETRA 209 12 17 220
ISENTRESS 195 30 19 202
SULFAMETHOXAZOLE-TRIMETHOPRIM 185 15 20 134
HYDROCODONE-ACETAMINOPHEN 175 0 S3 21 8
ATORVASTATIN CALCIUM 164 15 22 14
GEMFIBROZIL 157 0 23 63
AMLODIPINE BESYLATE 144 26 24 4
PROAIR HFA 140 0 25 40
INTELENCE 131 12 26 245
ZOLPIDEM TARTRATE 127 0 27 17
FLUTICASONE PROPIONATE 124 15 28 23
TRAZODONE HCL 117 11 29 37
RANITIDINE HCL 116 0 30 28
METFORMIN HCL 110 11 31 6
METHADONE HCL 94 11 S2 32 143
CARISOPRODOL 92 0 R 33 71
DIPHENOXYLATE-ATROPINE 89 0 34 237
LEXIVA 79 0 35 291
VIREAD 77 0 36 252
LOPERAMIDE 73 0 37 286
TRICOR 73 0 37 153
TRAMADOL HCL 73 0 37 25
PROMETHAZINE HCL 72 0 R 40 129
METOPROLOL TARTRATE 70 0 41 7
MIRTAZAPINE 64 0 42 68
SUSTIVA 64 12 42 277
DOXAZOSIN MESYLATE 63 0 44 62
METOPROLOL SUCCINATE 62 0 45 21
ATENOLOL 59 23 46 10
IBUPROFEN 57 0 47 75
AMITRIPTYLINE HCL 57 0 R 47 72
PANTOPRAZOLE SODIUM 56 0 49 27
LEVOTHYROXINE SODIUM 55 24 50 1
SELZENTRY 53 0 51 376
METOCLOPRAMIDE HCL 51 0 52 149
ZIAGEN 51 0 52 384
TRIAMCINOLONE ACETONIDE 51 0 52 137
FENOFIBRATE 50 0 55 55
LAMIVUDINE 50 0 55 388
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.